SeerPharma has a long-standing reputation for helping pharmaceutical and medical device companies establish new or upgrade existing GMP manufacturing facilities. The team is currently engaged in multiple facility projects across the APAC region, working on complex facility projects involving the manufacture of:
Validation 4.0 – A Near Future State
ISPE recently hosted a webinar on Validation 4.0 and where it sat within their ISPE Pharma 4.0TM Operation Model. It was with no surprise that an audience survey rated ‘documentation’ as the biggest hurdle / constraint to validation.
Global Perspective on Effective Management of Risk-based GMP
SeerPharma in partnership with the Life Sciences Industry Group of the SingaporeManufacturing Federation held its annual Symposium for 2017 in Singapore, March 16th to 17th. The event saw over 50 delegates from across the Asia-Pacific region attend. Companies from countries such as The Philippines, Malaysia, Singapore, Australia and Sri Lanka were
The Quality / GMP stream hosted by ISPE at this year’s ARCS congress was a great opportunity to explore the latest issues and trends. Feedback and questions raised during the Quality / GMP sessions identified three current areas of interest to many involved in this area of work. Namely the approach and use of Quality Management Systems, Validation...